The present study demonstrated that BJIKT combined with anti-PD-L1 antibody enhanced the infiltration of CD8+ T-cells and restored their function, which dramatically inhibited tumor growth in the MC38 CRC model. Here, CD8A is linked to colorectal carcinoma.